Shanghai Junsai Biotechnology
Latest round
- Series B
Last raised
- Aug 2025
Total raised
- Undisclosed
Investors
- 13
About Shanghai Junsai Biotechnology
Based in Shanghai, China and established in 2019, Shanghai Junsai Biotechnology is a tumor cell therapy developer that focuses on Tumor Infiltrating Lymphocyte and related drugs. The company's main business is development of innovative tumor infiltrating lymphocyte (TIL) based therapies for solid tumors and First-in-class/Best-in-class cell-based novel drugs. The products used in the field of recurrent refractory malignancies.
Who invested in Shanghai Junsai Biotechnology
13 investors across 4 rounds
See all investors in Shanghai Junsai Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shanghai Junsai Biotechnology
Who invested in Shanghai Junsai Biotechnology?
Shanghai Junsai Biotechnology has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanghai Junsai Biotechnology raised?
Shanghai Junsai Biotechnology has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Shanghai Junsai Biotechnology last raise money?
Shanghai Junsai Biotechnology's most recent round on record is a Series B, in Aug 2025.
What does Shanghai Junsai Biotechnology do?
Based in Shanghai, China and established in 2019, Shanghai Junsai Biotechnology is a tumor cell therapy developer that focuses on Tumor Infiltrating Lymphocyte and related drugs.
Where is Shanghai Junsai Biotechnology headquartered?
Shanghai Junsai Biotechnology is headquartered in Shanghai, China.
Which VCs invest in companies like Shanghai Junsai Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Shanghai Junsai Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Shanghai Junsai Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.